Cutaneomucosal manifestations of Behcet's disease;Manifestations cutaneo-muqueuses de la maladie de Behcet

Annales de Medecine Interne

Volumn 150, Issue 7, 1999, Pages 535-541

  Francès, Camille ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Aphthae; Behcet's disease; Pseudofolliculitis; Vasculitis

Indexed keywords

ACETYLSALICYLIC ACID; COLCHICINE; CORTICOSTEROID; DAPSONE; IMMUNOSUPPRESSIVE AGENT; THALIDOMIDE;

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; APHTHOUS STOMATITIS; APHTHOUS ULCER; BEHCET DISEASE; CLINICAL FEATURE; CORTICOSTEROID THERAPY; ERYTHEMA NODOSUM; FOLLICULITIS; GENITAL ULCER; HISTOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTIC INFILTRATION; NEUTROPHIL; PYODERMA GANGRENOSUM; REVIEW; SKIN MANIFESTATION; FEMALE; GENITAL SYSTEM DISEASE; GYNECOLOGIC DISEASE; HUMAN; MALE; MUCOSA; SKIN DISEASE; ULCER;

BEHCET SYNDROME; FEMALE; GENITAL DISEASES, FEMALE; GENITAL DISEASES, MALE; HUMANS; MALE; MUCOUS MEMBRANE; SKIN DISEASES; STOMATITIS, APHTHOUS; ULCER;

EID: 0033397179     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. International Study group for Behçet's disease: Criteria for diagnosis of Behçet's disease. Lancet, 1990; 335: 1078-80.
2. CHAMS C, MANSOORI P, SHAHRAM F, AKBARIAN M, GHARIBDOOST F, DAVATCHI F: Iconography of mucocutaneous lesions of Behçet's disease. In: Behçet's disease. B WECHSLER, P GODEAU editors. Elsevier Science Publishers BV, Amsterdam 1993: 359-62.
3. MANGELSDORF HC, WHITE WL, JORIZZO JL: Behçet's disease. Report of twenty five patients from the United States with prominent mucocutaneous involvement. J Am Acad Dermatol, 1996; 34: 745-50.
4. GHAYAD E, TOHME A: Behçet's disease in Lebanon: report of 100 cases. J Med Liban, 1995; 43: 2-7.
5. ROGERS RS: Recurrent aphthous stomatitis: clinical characteristics and immunopathogenesis. J Invest Dermatol, 1977; 69: 499-509.
6. ARBEESFELD SJ, KURBAN AK: Behçet's disease. New perspectives on an enigmatic syndrome. J Am Acad Dermatol, 1988; 19: 767-79.
7. HOMMA T, SAITO T, FUJIOKA Y: Intraepithelial atypical lymphocytes in oral lesions of Behçet's syndrome. Arch Dermatol, 1981; 117: 83-5.
8. GHATE JV, JORIZZO JL: Behçet's disease and complex aphthosis. J Am Acad Dermatol, 1999; 40: 1-18.
9. MAIN DMG, CHAMBERLAIN MA: Clinical practice. Clinical differentiation of oral ulceration in Behçet's disease. Br J Rheumatol, 1992; 31: 767-70.
10. CUNY JF, CHAUVEL F, SCHMUTZ JL, BORDIGONI P, WEBER M, BEUREY J : Éruption pseudo-lupique chez une mère transmettrice de la granulomatose septique chronique liée à I'X. Ann Dermatol Venereol, 1990 ; 117: 713-8.
11. AGBO-GODEAU S, JOLY P, LAURET P, SZPIRGLAS R, SZPIRGLAS H: Association of major aphthous ulcers and nicorandil (letter). Lancet, 1998; 352: 1598-9.
12. LOGEART I, BLONDON H, CAULIN C: Ulcère aigu de la vulve au cours d'une primo-infection au virus d'Epstein-Barr. Presse Med, 1998; 27: 571-2.
13. ORME RL, NORDLUND JJ, BARICH L, BROWN T: The MAGIC syndrome (mouth and genital ulcers with inflamed cartilage). Arch Dermatol, 1990; 126: 940-4.
14. CALLEN JP: Gastrointestinal diseases. In: CALLEN JP, ed. Cutaneous Aspects of Internal Diseases. London: Year Book Medical Publishers, 1981: 511-24.
15. BUDAK-ALPDOGAN T, DEMIRCAY Z, ALPDOGAN O, DIRESKENELI H, ERGUN T, BAYIK M et al.: Behçet's disease in patients with chronic myeloid leukaemia patients: possible role of interferon alpha treatment in the occurrence of Behçet's symptoms. Ann Hematol, 1997; 74: 45-8.
16. INOUE C, ITOH R, KAWA Y, MIZOGUCHI M: Pathogenesis of mucocutaneous lesions in Behçet's disease. J Dermatol, 1994; 21: 874-80.
17. ITOH R. TAKENAKA T, OKITSU-NEGISHI S, MATSUSHIMA K, MIZOGUCHI M: Interleukin 8 in Behçet's disease. J Dermatol, 1994; 21: 397-404.
18. TREUDLER R, ZOUBOULIS CC, BUTTNER P, DETMAR M, ORFANOS CE: Enhanced interaction of patients's lymphocytes with human dermal microvascular endothelial cell cultures in active Adamantiades-Behçet's disease. Arch Dermatol, 1996; 132: 1323-9.
19. HUI-LI S, ZHENG-JI H: Study on cutaneous lesions in Behçet's disease and meanings of relative laboratory parameters. In: Behçet's disease. WECHSLER B, GODEAU P editors. Elsevier Science Publishers BV, Amsterdam 1993: 325-30.
20. HAMZA M, AYED K, ZRIBI A : Maladie de Behçet. In : Les maladies systémiques. KAHN JM, PELTIER AP, MEYER O, PIETTE JC editors. Flammarion, Paris, 1991 : 917-47.
21. ALPSOY E, AKTEKIN M, ER H, DURUSOY C, YILMAZ E: A randomized, controlled and blinded study of papulopustular lesions in Turkish Behçet's patients. Int J Dermatol, 1998; 37: 839-42.
22. MOCHIZUKI M, MORITA E, YAMAMOTO S, YAMANA S: Characteristics of T cell lines established from skin lesions of Behçet's disease. J Dermatol Sci, 1997; 15: 9-13.
23. WECHSLER J : Lésions anatomopathologiques au cours de la maladie de Behçet. Sem Hôp Paris, 1986 ; 62 : 1337-40.
24. ERGUN T, GURBUZ O, DOGUSOY G, MAT C, YAZICI H: Histopathologic features of the spontaneous pustular lesions of Behçet's disease. Int J Dermatol, 1998; 37: 194-6.
25. MAGRO CM, CROWSON AM: Sterile neutrophilic folliculitis with perifollicular vasculopathy: a distinctive cutaneous reaction pattern reflecting systemic disease. J Cut Pathol, 1998; 25: 215-21.
26. CHEN KR, KAWAHARA Y, MIYAKAWA S, NISHIKAWA T: Cutaneous vasculitis in Behçet's disease: a clinical and histological studies in 20 patients. J Am Acad Dermatol, 1997; 36: 689-96.
27. JORIZZO JL, SOLOMAN AR, CAVALLO T: Behçet's syndrome; immunopathological and histopathological assessment of pathergy lesions is useful in diagnosis and follow up. Arch Pathol Lab Med, 1985; 109: 747-51.
28. SU WPD, CHUN SI, LEE S, ROGERS RS: Histological spectrum of erythema nodosum lesions in Behçet's disease. In: O'DUFFY JD, KOKMEN E editors. Behçet's disease: basic and clinical aspects. New York: Marcel Dekker, Inc, 1991; 229-40.
29. HOMMA T, BANG D, SAITO T, NAKAGAWA S, UEKI H, LEE S: Ultrastructure of lymphocyte-mediated fat-cell lysis in erythema nodosum-like lesions of Behçet's syndrome. Arch Dermatol, 1987; 123: 1650-4.
30. SENTURK T, AYDINTUG O, KUZU I, TOKGOZ G, GURLER A, TULUNAY O: Adhesion molecule expression in erythema nodosum-like lesions in Behçet's disease. A histopathological and immunohistochemical study. Rheumatol Int, 1998; 18: 51-7.
31. LEE ES, LEE SH, BANG D, LEE S: Sweet's syndrome-like skin lesions in Behçet's syndrome: an additional cutaneous manifestation. In: O'DUFFY JD, KOKMEN E editors. Behçet's disease: basic and clinical aspects. New York: Marcel Dekker, Inc, 1991; 223-7.
32. RUSTIN MHA, GILKES JJH, ROBINSON TWE: Pyoderma gangrenosum associated with Behçet's disease; treatment with thalidomide. Arch Dermatol, 1990; 23: 941-4.
33. ARMAS JB, DAVIES J, DAVIS M, LOVELL C, MCHUGH N: Atypical Behçet's disease with peripheral erosive arthropathy and pyoderma gangrenosum. Clin Exp Dermatol, 1992; 10: 177-80.
34. LEE ES, BANG D, LEE S: Dermatologic manifestations of Behçet's disease. Yonsei Med J, 1997; 38: 380-9.
35. CANTINI F, SALVARINI C, NICCOLI L, SENESI C, TRUGLIA MC, PADULA A, OLIVIERI I: Behçet's disease with unusual cutaneous lesions. J Rheumatol, 1998; 25: 2469-72.
36. FRIEDMAN-BIRNBAUM R, BERGMAN R, AIZEN E: Sensitivity and specificity of pathergy test results in Israeli patients with Behçet's disease. Cutis, 1990; 45: 261-4.
37. GILHAR A, WINTERSTEIN G, TURANI H, LANDAU J, ETZIONI A: Skin hypereactivity response (pathergy) in Behçet's disease. J Am Acad Dermatol, 1989; 21: 547-52.
38. CAKIR N, YAZICI H, CHAMBERLAIN MA et al.: Response to intradermal injection of monosodium urate crystals in Behçet's syndrome. Ann Rheum Dis, 1991; 50: 634-6.
39. DILSEN N, KONIÇE M, ARAL O, INANÇ M, GÜL A: Comparative study of the skin pathergy test with blunt and sharp needles in Behçet's disease comfirmed specificity but decreased sensitivity with sharp needles. Ann Rheum Dis, 1993; 52: 823-5.
40. WECHSLER J, WECHSLER B, HERREMAN G et al. : Maladie de Behçet. Etude en immunofluorescence de l'intradermo-réaction à l'eau distillée. Valeur diagnostique à propos de 50 malades. Med Interne, 1981 ; 16 : 112-7.
41. WECHSLER J, WECHSLER B, REVUZ J, GODEAU P: Skin hyperreactivity response (pathergy) in Behçet's disease. Useful of direct immunofluorescence. J Am Acad Dermatol, 1990; 23: 329-30.
42. ERGUN T, GURBUZ O, HARVELL J, JORIZZO J, WHITE W: The histopathology of pathergy: a chronologic study of skin hyperreactivity in Behçet's disease. Int J Dermatol, 1998; 37: 929-33.
43. GUL A, ESIN S, DILSEN N, KONICE M, WIGZELL H, BIBERFELD P: Immunohistology of skin pathergy reaction in Behçet's disease. Br J Dermatol, 1995; 132: 901-7.
44. BUDAK-ALPDOGAN T, DEMIRCAY Z, ALPDOGAN O, DIRESKENELI H, ERGUN T, OZTURK A et al.: Skin hyperreactivity of Behçet's patients (pathergy reaction) is also positive in interferon alpha-treated chronic myeloid leukaemia patients, indicating similarly altered neutrophil functions in both disorders. Br J Rheumatol, 1998; 37: 1148-51.
45. MANSOORI P, CHAMS C, DAVATCHI F et al: Relationship of pathergy phenomen and Behçet's disease manifestations. In: Behçet's disease. WECHSLER B, GODEAU P editors. Elsevier Science Publishers BV, Amsterdam 1993: 367-9.
46. JORIZZO JL, HUDSON RD, SCHMALSTIEG FC et al.: Behçet's syndrome: immune regulation, circulating immune complexes, neutrophil migration and colchicine therapy. J Am Acad Dermatol, 1984; 10: 205-14.
47. MIYACHI Y, TANGIGUCHI S, OZAKI M et al: Colchicine in the treatment of cutaneous manifestations of Behçet's disease. Br J Dermatol, 1981; 104: 67-9.
48. MIZUSHIMA Y, MATSUMURA W, MORI M: Chemotaxis of leukocytes and colchicine treatment in Behçet's disease. Br J Rheumatol, 1979; 6: 108-9.
49. AKTULGA E, ALTAC M, MUFTUOGLU A et al.: A double blind study of colchicine in Behçet's disease. Haematologica, 1980; 65: 399-402.
50. SHARQUIE KE: Suppression of Behçet's disease with dapsone. Br J Dermatol, 1984; 110: 493-4.
51. HAMURYUDAN V, MAT C, SAIP S et al.: Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized, double-blind, placebo-controlled trial. Ann Intern Med, 1998; 15: 443-50.
52. REVUZ J, GUILLAUME JC, JANIER M: Crossover study of thalidomide vs placebo in severe recurrent aphthous stomatitis. Arch Dermatol, 1990; 126: 923-7.
53. GARDNER-MEDWIN JM, SMITH NJ, POWELL RJ: Clinical experience with thalidomide in the management of severre oral and genital ulceration in condition such as Behçet's disease: use of neurophysiologic studies to detect thalidomide neuropathy. Ann Rheum Dis, 1994; 53: 828-32.
54. GOMPEL A, FRANCÈS C, CORDOLIANI F, PIETTE JC, PIETTE AM: Ovarian failure induced by thalidomide in complex aphthosis (letter). Arthritis Rheum in press.
55. ALPSOY E, YILMAZ E, BASARAN E: Interferon therapy for Behçet's disease. J am Acad Dermatol, 1994; 31: 617-9.
56. HAMURYUDAN V, MORAL F, YURDAKUL S, MAT C, TUZUN Y, OZYAZGAN Y et al.: Systemic interferon alpha 2b treatment in Behçet's syndrome. J Rheumatol, 1994; 31: 617-9.
57. O'DUFFY JD, CALAMIA K, COHEN S, GORONZY JJ, HERMAN D, JORIZZO J et al.: Alpha-interferon treatment of Behçet's disease. J Rheumatol, 1998; 25: 1938-44.
58. AVCI O, GURLER N, GUNES AT: Efficacy of cyclosporine on mucocutaneous manifestations of Behçet's disease. J Am Acad Dermatol, 1997; 36: 796-7.